Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov

Slide Presentation from the AHRQ 2007 Annual Conference


Results

Text Description is below the image.

Metoclopramide users were over three times more likely to begin use of L-dopa therapy compared with non-users (OR=3.09; 95% CI 2.25 to 4.26).

Notes:

Our results—We found that metoclopramide users were over three times more likely to begin levodopa therapy as compared with non-users of metoclopramide.


Previous Slide Previous Slide         Contents         Next Slide Next Slide


 

AHRQ Advancing Excellence in Health Care